Search research articles
Contact Us
Filters
Showing results (71-80 of 148) with videos related to
Page
of 15
Sort By:
Journal of Perinatal Medicine
|
January 1, 1994
Antenatal betamethasone-dose-effects on fetal rat lung morphology and surfactant
A K Lohninger, P Böck, H Salzer, et al.
Gynakologische Rundschau
|
January 1, 1990
[Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?]
P Sevelda, A Rosen, M Barrada, et al.
Gynecologic Oncology
|
January 1, 1997
Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy
K Mayerhofer, E Kucera, H Zeisler, et al.
Cancer
|
August 26, 1998
The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review
A Obermair, A Handisurya, A Kaider, et al.
Wiener Klinische Wochenschrift
|
February 17, 1989
[Side effects of adjuvant therapies of breast cancer: their significance for the patient]
M Langer, H Flores-Genger, P Sevelda, et al.
British Journal of Cancer
|
November 26, 1999
CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer
C Peters-Engl, A Obermair, H Heinzl, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
October 17, 1998
Psammocarcinoma of the peritoneum diagnosed during operative laparoscopy
R Lehner, M Jaindl, R Wenzl, et al.
Breast Cancer Research and Treatment
|
January 5, 2002
Lunar phases and survival of breast cancer patients--a statistical analysis of 3,757 cases
C Peters-Engl, W Frank, F Kerschbaum, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie
|
May 1, 1988
[Carnitine levels in pregnancy]
H Genger, P Sevelda, E Vytiska-Binstorfer, et al.
Cancer Investigation
|
February 10, 2006
Ifosfamide/mesna as salvage therapy in platinum pretreated ovarian cancer patients--long-term results of a phase II study
Martina Baur, B Fazeny-Doerner, M Hudec, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 148) with videos related to
Sort By:
Page
of 15
Journal of Perinatal Medicine
|
January 1, 1994
Antenatal betamethasone-dose-effects on fetal rat lung morphology and surfactant
A K Lohninger, P Böck, H Salzer, et al.
Gynakologische Rundschau
|
January 1, 1990
[Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?]
P Sevelda, A Rosen, M Barrada, et al.
Gynecologic Oncology
|
January 1, 1997
Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy
K Mayerhofer, E Kucera, H Zeisler, et al.
Cancer
|
August 26, 1998
The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review
A Obermair, A Handisurya, A Kaider, et al.
Wiener Klinische Wochenschrift
|
February 17, 1989
[Side effects of adjuvant therapies of breast cancer: their significance for the patient]
M Langer, H Flores-Genger, P Sevelda, et al.
British Journal of Cancer
|
November 26, 1999
CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer
C Peters-Engl, A Obermair, H Heinzl, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
October 17, 1998
Psammocarcinoma of the peritoneum diagnosed during operative laparoscopy
R Lehner, M Jaindl, R Wenzl, et al.
Breast Cancer Research and Treatment
|
January 5, 2002
Lunar phases and survival of breast cancer patients--a statistical analysis of 3,757 cases
C Peters-Engl, W Frank, F Kerschbaum, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie
|
May 1, 1988
[Carnitine levels in pregnancy]
H Genger, P Sevelda, E Vytiska-Binstorfer, et al.
Cancer Investigation
|
February 10, 2006
Ifosfamide/mesna as salvage therapy in platinum pretreated ovarian cancer patients--long-term results of a phase II study
Martina Baur, B Fazeny-Doerner, M Hudec, et al.
Page
of 15